Insulin: a novel agent in the pathogenesis of prostate cancer.
about
Association Between Average Daily Television Viewing Time and Chronic Obstructive Pulmonary Disease-Related Mortality: Findings From the Japan Collaborative Cohort StudyObesity affects the biopsy-mediated detection of prostate cancer, particularly high-grade prostate cancer: a dose-response meta-analysis of 29,464 patients.Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.Finding minimum gene subsets with heuristic breadth-first search algorithm for robust tumor classification.Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancerHigher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men.Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis.Prostate cancer cell proliferation and angiogenesis in different obese mice models.Dietary patterns as predictors of prostate cancer in Jamaican men.Prospective cohort study on television viewing time and incidence of lung cancer: findings from the Japan Collaborative Cohort Study.Influence of obesity on tumour volume in patients with prostate cancer.The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?The andrologist's contribution to a better life for ageing men: part 2.Elevated C-Peptides, Abdominal Obesity, and Abnormal Adipokine Profile are Associated With Higher Gleason Scores in Prostate Cancer.Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study
P2860
Q28394893-B99AA300-6835-4EBE-81A2-C4C67CDFCA39Q34128835-DD379715-655B-43D2-A34E-F563E1BA3CBAQ34203868-7C9E833A-C6BB-4D2F-9EE5-271FCA1B16D2Q34351520-33692FEB-AFC8-4734-8A75-78ECB1438695Q35051478-1DBD6D52-919D-45D0-9EE9-4C2157EE77D7Q35599285-E3033E91-83CF-4682-9180-41E7D7EE4C20Q36255272-B9C93428-3F2B-4113-B64A-600F7832A87AQ38342105-D77A08D8-2CD7-430D-AF68-685B49B3F9B0Q43947796-A04C3BAA-7046-495F-8022-E840C58637BDQ45236937-891D2DE7-C44F-400E-BF47-796DFFF4C7A1Q46770186-A449192A-C41C-4055-92A3-A24B4CDBD0DBQ47379977-CB682D80-4380-4087-AE4A-C88F1A128FF7Q49170674-F9F7C2F4-0AC7-42B8-A6E8-57316712F36DQ51278345-87C2D302-EBC6-42AB-ABF5-2BC54938A832Q57818346-E7A82365-4A70-460F-AC08-F71EC4A8A9A4
P2860
Insulin: a novel agent in the pathogenesis of prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin: a novel agent in the pathogenesis of prostate cancer.
@en
Insulin: a novel agent in the pathogenesis of prostate cancer.
@nl
type
label
Insulin: a novel agent in the pathogenesis of prostate cancer.
@en
Insulin: a novel agent in the pathogenesis of prostate cancer.
@nl
prefLabel
Insulin: a novel agent in the pathogenesis of prostate cancer.
@en
Insulin: a novel agent in the pathogenesis of prostate cancer.
@nl
P2860
P1476
Insulin: a novel agent in the pathogenesis of prostate cancer.
@en
P2093
Hanumanthappa Nandeesha
P2860
P304
P356
10.1007/S11255-008-9440-X
P577
2008-07-30T00:00:00Z